The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients
暂无分享，去创建一个
K. Stingl | T. Peters | C. Hoyng | F. Holz | A. Lotery | S. Schmitz-Valckenberg | C. Boon | Philipp T. Möller | P. Herrmann | M. Battaglia Parodi | M. Fsadni | T. Wheeler-Schilling | O. Jungmann | P. Dhooge | W. Klein | H. Müller